Appelbaum; Edward Robert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Appelbaum; Edward Robert.The latest application filed is for "recombinant il-5 antagonists useful in treatment of il-5 mediated disorders".

Company Profile

0.8.5

Appelbaum; Edward Robert - Blue Bell PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders Grant 7,982,005 - Ames , et al. July 19, 2	2011-07-19
Recombinant Il-5 Antagonists Useful In Treatment Of Il-5 Mediated Disorders App 20100316634 - Ames; Robert S. ; et al.	2010-12-16
Recombinant Il-5 Antagonists Useful In Treatment Of Il-5 Mediated Disorders App 20090017020 - AMES; Robert S. ; et al.	2009-01-15
Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders Grant 7,399,837 - Ames , et al. July 15, 2	2008-07-15
Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders App 20060029594 - Ames; Robert S. ; et al.	2006-02-09
Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders Grant 6,946,130 - Ames , et al. September 20, 2	2005-09-20
Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders App 20040156850 - Ames, Robert S. ; et al.	2004-08-12
Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders App 20030059429 - Ames, Robert S. ; et al.	2003-03-27
Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders Grant 6,129,913 - Ames , et al. October 10, 2	2000-10-10
Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders Grant 5,851,525 - Ames, Jr. , et al. December 22, 1	1998-12-22
Method for treatment and diagnosis of IL-5 mediated disorders Grant 5,783,184 - Appelbaum , et al. July 21, 1	1998-07-21
Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders Grant 5,693,323 - Ames, Jr. , et al. December 2, 1	1997-12-02
DNA encoding recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders Grant 5,683,892 - Ames, Jr. , et al. November 4, 1	1997-11-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.